Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conservative Treatment vs Surgery for GLM with Psychiatric Disorders
NCT05395949Enrolling by invitation
- Sponsor
- Wuhan University
- Start
- Jan 2019
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of prednisone and methotrexate in Granulomatous lobular mastitis (GLM) (2 arms), sponsored by Wuhan University. Primary endpoints: Recurrence rate at 1 year and Breast appearance and cosmetic effect score at 1 year. Started Jan 2019; status: enrolling by invitation.
02
Drugs
prednisonemethotrexate
03
Conditions
Granulomatous lobular mastitis (GLM)
Beyond the preview
Go deeper on NCT05395949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05395949.